
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent Advances in Automated Structure-Based De Novo Drug Design
Yidan Tang, Rocco Moretti, Jens Meiler
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 6, pp. 1794-1805
Open Access | Times Cited: 27
Yidan Tang, Rocco Moretti, Jens Meiler
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 6, pp. 1794-1805
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Recent Knowledge in Drug Design and Development: Automation and Advancement
Kusum Gurung, Saurav Kumar Mishra, Tabsum Chhetri, et al.
(2025), pp. 153-181
Closed Access | Times Cited: 1
Kusum Gurung, Saurav Kumar Mishra, Tabsum Chhetri, et al.
(2025), pp. 153-181
Closed Access | Times Cited: 1
The Physics-AI Dialogue in Drug Design
Pablo Andrés Vargas-Rosales, Amedeo Caflisch
RSC Medicinal Chemistry (2025)
Open Access | Times Cited: 1
Pablo Andrés Vargas-Rosales, Amedeo Caflisch
RSC Medicinal Chemistry (2025)
Open Access | Times Cited: 1
New strategies to enhance the efficiency and precision of drug discovery
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Qi An, Liang Huang, Chuan Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102295-102295
Open Access | Times Cited: 8
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102295-102295
Open Access | Times Cited: 8
Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence
Ahrum Son, Jongham Park, Woojin Kim, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4626-4626
Open Access | Times Cited: 5
Ahrum Son, Jongham Park, Woojin Kim, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4626-4626
Open Access | Times Cited: 5
Rationalizing protein–ligand interactions via the effective fragment potential method and structural data from classical molecular dynamics
Andrés S. Urbina, Lyudmila V. Slipchenko
The Journal of Chemical Physics (2025) Vol. 162, Iss. 4
Closed Access
Andrés S. Urbina, Lyudmila V. Slipchenko
The Journal of Chemical Physics (2025) Vol. 162, Iss. 4
Closed Access
Cullin-RING Ubiquitin Ligases in Neurodevelopment and Neurodevelopmental Disorders
Honoka Ashitomi, Tadashi Nakagawa, Makiko Nakagawa, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 810-810
Open Access
Honoka Ashitomi, Tadashi Nakagawa, Makiko Nakagawa, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 810-810
Open Access
Protein–Ligand Interaction Energies from Quantum-Chemical Fragmentation Methods: Upgrading the MFCC-Scheme with Many-Body Contributions
Johannes R. Vornweg, Christoph R. Jacob
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 47, pp. 11597-11606
Open Access | Times Cited: 3
Johannes R. Vornweg, Christoph R. Jacob
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 47, pp. 11597-11606
Open Access | Times Cited: 3
Methods for Theoretical Treatment of Local Fields in Proteins and Enzymes
Mark E. Eberhart, Anastassia N. Alexandrova, Pujan Ajmera, et al.
Chemical Reviews (2025)
Closed Access
Mark E. Eberhart, Anastassia N. Alexandrova, Pujan Ajmera, et al.
Chemical Reviews (2025)
Closed Access
Recent Advances in Medicinal Chemistry Strategies for the Development of METTL3 Inhibitors
G. Li, Wei Chen, Dan Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117560-117560
Closed Access
G. Li, Wei Chen, Dan Liu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117560-117560
Closed Access
Fragment Libraries from Large and Novel Synthetic Compounds and Natural Products: A Comparative Chemoinformatic Analysis
Verónica Ramírez-Cid, Ana L. Chávez‐Hernández, Oswaldo López, et al.
ACS Omega (2025)
Open Access
Verónica Ramírez-Cid, Ana L. Chávez‐Hernández, Oswaldo López, et al.
ACS Omega (2025)
Open Access
Evaluating AutoGrow4 - an open-source toolkit for semi-automated computer-aided drug discovery.
Davide Bassani, Matteo Pavan, Stefano Moro
Expert Opinion on Drug Discovery (2025), pp. 1-10
Closed Access
Davide Bassani, Matteo Pavan, Stefano Moro
Expert Opinion on Drug Discovery (2025), pp. 1-10
Closed Access
A computational workflow to determine drug candidates alternative to aminoglycosides targeting the decoding center of E. coli ribosome
Merve Yuce, Beril Ates, Nesrin İsil Yasar, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 131, pp. 108817-108817
Closed Access | Times Cited: 2
Merve Yuce, Beril Ates, Nesrin İsil Yasar, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 131, pp. 108817-108817
Closed Access | Times Cited: 2
Utilizing Omics Technologies and Machine Learning to Improve Predictive Toxicology
Ahrum Son, Jongham Park, Woojin Kim, et al.
(2024)
Open Access | Times Cited: 2
Ahrum Son, Jongham Park, Woojin Kim, et al.
(2024)
Open Access | Times Cited: 2
Integrating Computational Design and Experimental Approaches for Next-Generation Biologics
Ahrum Son, Jongham Park, Woojin Kim, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1073-1073
Open Access | Times Cited: 1
Ahrum Son, Jongham Park, Woojin Kim, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1073-1073
Open Access | Times Cited: 1
Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance
Karl A. Glen, Iain L. Lamont
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Karl A. Glen, Iain L. Lamont
Microbiology Spectrum (2024)
Open Access | Times Cited: 1
Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy
Areum Sohn, Jongham Park, Woojin Kim, et al.
Toxics (2024) Vol. 12, Iss. 11, pp. 822-822
Open Access | Times Cited: 1
Areum Sohn, Jongham Park, Woojin Kim, et al.
Toxics (2024) Vol. 12, Iss. 11, pp. 822-822
Open Access | Times Cited: 1
Novel drug discovery approaches for MMP-13 inhibitors in the treatment of osteoarthritis
Yi Wang
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130009-130009
Closed Access | Times Cited: 1
Yi Wang
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130009-130009
Closed Access | Times Cited: 1
Heterogenous Expression and Purification of Lipid II Flippase from Staphylococcus aureus
Yuan Zheng, Wai-Hong Chung, Yun‐Chung Leung, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 5, pp. 386-394
Open Access
Yuan Zheng, Wai-Hong Chung, Yun‐Chung Leung, et al.
Protein and Peptide Letters (2024) Vol. 31, Iss. 5, pp. 386-394
Open Access
A Generative Evolutionary Many-Objective Framework: A Case Study in Antimicrobial Agent Design
Matheus Müller Pereira da Silva, Jaqueline S. Angelo, Isabella Alvim Guedes, et al.
Proceedings of the Genetic and Evolutionary Computation Conference Companion (2024), pp. 1623-1630
Closed Access
Matheus Müller Pereira da Silva, Jaqueline S. Angelo, Isabella Alvim Guedes, et al.
Proceedings of the Genetic and Evolutionary Computation Conference Companion (2024), pp. 1623-1630
Closed Access
Computational Approaches for Structure-Assisted Drug Discovery and Repurposing
Anand Kumar Pandey, Shalja Verma
(2024), pp. 163-192
Closed Access
Anand Kumar Pandey, Shalja Verma
(2024), pp. 163-192
Closed Access
Prominent Neuroprotective Potential of Indole-2-N-methylpropargylamine: High Affinity and Irreversible Inhibition Efficiency towards Monoamine Oxidase B Revealed by Computational Scaffold Analysis
Lucija Vrban, Robert Vianello
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1292-1292
Open Access
Lucija Vrban, Robert Vianello
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1292-1292
Open Access
Computational Chemistry Methods in Cancer Treatment: A Molecular Perspective
Erik Lindahl
(2024)
Open Access
Erik Lindahl
(2024)
Open Access
Protein-ligand co-design: a case for improving binding affinity between Type II NADH:quinone oxidoreductase and quinones
Vladimir Porokhin, Anne M. Brown, Soha Hassoun
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vladimir Porokhin, Anne M. Brown, Soha Hassoun
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Structure-Based Design, Virtual Screening, and Discovery of Novel Patulin Derivatives as Biogenic Photosystem II Inhibiting Herbicides
He Wang, Jing Zhang, Yu Ji, et al.
Plants (2024) Vol. 13, Iss. 12, pp. 1710-1710
Open Access
He Wang, Jing Zhang, Yu Ji, et al.
Plants (2024) Vol. 13, Iss. 12, pp. 1710-1710
Open Access